Foghorn Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Foghorn Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2024.
  • Foghorn Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 62.6M shares, a 49% increase year-over-year.
  • Foghorn Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 42M shares, a 0.92% increase from 2022.
  • Foghorn Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 41.6M shares, a 11.9% increase from 2021.
  • Foghorn Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 37.2M shares, a 236% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 62.6M +20.6M +49% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 51.6M +9.75M +23.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 42.4M +618K +1.48% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 42M +383K +0.92% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 42M +353K +0.85% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 41.8M +310K +0.75% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 41.8M +441K +1.07% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 41.6M +4.42M +11.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 41.7M +4.7M +12.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 41.5M +4.67M +12.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 41.4M +4.55M +12.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 37.2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 37M +31.1M +528% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 36.8M +31.4M +580% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 36.8M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q3 2020 5.88M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 5.42M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.